The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline and early post-infusion biomarkers associated with optimal response to idecabtagene vicleucel (ide-cel) in the KarMMa-3 study of triple-class–exposed (TCE) relapsed and refractory multiple myeloma (RRMM).
 
Julia Piasecki
Employment - Bristol-Myers Squibb
 
Keyur Desai
Employment - Bristol-Myers Squibb
 
Carolyn Courtney
Employment - Bristol-Myers Squibb
 
Ethan Thompson
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jim Pratt
Employment - Bristol-Myers Squibb
 
Noopur S. Raje
Consulting or Advisory Role - 2seventy bio; Abbvie; Amgen; Bristol-Myers Squibb; Caribou Biosciences; Immuneel Therapeutics; Janssen; Sanofi
Research Funding - 2seventy bio
 
Krina K. Patel
Consulting or Advisory Role - Arcellx; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cellectis; Janssen; Karyopharm Therapeutics; Merck; Pfizer; Takeda; Takeda
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; Poseida; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Marc S. Raab
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Takeda
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi; Takeda
 
Mark Cook
Employment - Bristol-Myers Squibb
 
Katy L. Simonsen
Employment - Bristol-Myers Squibb
 
Mihaela Popa McKiver
Employment - Briston Myers Squibb
Stock and Other Ownership Interests - Briston Myers Squibb
 
Shari Kaiser
Employment - Bristol-Myers Squibb
 
Nathan Martin
Employment - Bristol-Myers Squibb